Head of Israel’s National Security Council Convenes Meeting on Gaza Ethnic Cleansing Plan

Holy Grail In Cancer Treatment? Moderna Erupts After Melanoma Vaccine Late-Stage Trial Success Moderna's shares soared as much as 83% in premarket trading in New York after its personalized cancer vaccine, developed in collaboration with Merck & Co., reduced the risk of melanoma returning in a large, late-stage trial. The result marks the first positive Phase 3 trial for a personalized cancer vaccine by any company.  The study met its primary endpoint by showing that the cancer vaccine, called intismeran autogene, combined with Merck's blockbuster immunotherapy Keytruda, improved recurrence-free survival compared...

USAF Seeks 'Dronebuster' Anti-Jammer Gun To Protect Nuclear-Strike Base Whether it's data centers, critical infrastructure, stadiums, corporate headquarters, or even military bases, the U.S. remains largely unprepared to combat one-way attack drones, including Category 1 through 3 drones, because a critical layer of cheap, scalable counter-UAS technology is missing. The proliferation of low-cost drones across Eurasian war zones, from the Ukraine-Russia war to the US-Iran conflict in the Middle East, has permanently changed the course of modern warfare.  One-way attack drones and FPVs have exposed a missing layer of affordable air defense...

UK Mulls Military Support For Saudis Against Houthis After MbS Appeal Amid ongoing Saudi humiliation as the Houthis have rapidly expanded their territory in Yemen, which involved a 36-hour period last week where the rebels took control of the country's entire Red Sea coast, Crown Prince Mohammed bin Salman (MbS) is desperately seeking military help from key allies in the West and regionally. Already rejected by the Trump administration (other than some few dozen American advisors being brought into the kingdom to help guide a response), Britain is weighing whether to step up. According to...